News

Pfizer And Touchlight Enter Into A Patent Licence Agreement

Pfizer and another pharmaceutical major, Touchlight, have come to a deal on a significant non-exclusive patent licence. Touchlight is a firm that focuses on enzymatic...

AstraZeneca, GSK Overcame Q2 Issues While Roche Stocks Fell

The standard response to any poor performance is to blame the supply chain, which has almost attained the status of a joke. However, it is...

FDA Allows Licenced Pharmacists To Sell Paxlovid From Pfizer

On July 6, the US Food and Drug Administration modified the COVID-19 antiviral drug Paxlovid's emergency use authorization to permit state-licensed pharmacists to recommend the medication...

Deloitte Latest Survey – Mature R&D Yields Enterprise Value

According to the third Real-World Evidence (RWE) benchmarking survey published in June 2022 by Deloitte, there is a segmentation of outcomes between businesses with more...

Sanofi Starts Fund For The Concerned In Low-Income Nations

The Paris-based pharmaceutical company is setting up a fund to assist companies who want to provide healthcare solutions in neglected areas. The objective is to...

Novel Ovarian Cancer Treatment By GSK Approved In Singapore

The oral, once-daily Zejula (niraparib) tablet, a first-line and recurrent upkeep care for women with advanced epithelial high-grade ovarian, fallopian tube, or primary peritoneal cancer...

The NHS Saves £1.2 Billion On Medications Over Three...

The NHS has used its purchasing power to negotiate lower rates for dozens of hospital medications, saving taxpayers £1.2 billion in only three years while...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read